Advertisement
Screener

MPM BioImpact LLC Historic Quarter Change: USA Other Stocks, Sold Out

MPM BioImpact LLC historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, MPM BioImpact LLC opened 5 positions, added to 5, reduced 5 and sold out of 11.

  • Q4 2025: Stock Wave Life Sciences PTE LTD; Country of operation —; Class Common; Shares before 1,505,262.
  • Q3 2025: Stock Veru Inc.; Country of operation United States; Class Common; Shares before 4,911,948.
  • Q1 2025: Stock Sutro Biopharma, Inc.; Country of operation United States; Class Common; Shares before 2,160,062.
  • Q3 2024: Stock MORPHIC HOLDING INC; Country of operation United States; Class Common; Shares before 369,384.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1687078), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-13); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2019-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2025Wave Life Sciences PTE LTD
CUSIP Y95308105
Common1,505,2620-1,505,262$11,018,518$0-$11,018,5182026-02-17
Q3 2025Veru Inc.
CUSIP 92536C103
United StatesCommon4,911,9480-4,911,948$2,857,771$0-$2,857,7712025-11-14
Q1 2025Sutro Biopharma, Inc.
CUSIP 869367102
United StatesCommon2,160,0620-2,160,062$3,974,514$0-$3,974,5142025-05-15
Q3 2024MORPHIC HOLDING INC
CUSIP 61775R105
United StatesCommon369,3840-369,384$12,584,913$0-$12,584,9132024-11-13
Q3 2024Verve Therapeutics, Inc
CUSIP 92539P101
United StatesCommon638,1630-638,163$3,114,235$0-$3,114,2352024-11-13
Q3 2024Allakos
CUSIP 01671P100
United StatesCommon344,9000-344,900$344,900$0-$344,9002024-11-13
Q2 2024Immatics NV
CUSIP N44445909
Common395,2370-395,237$4,153,941$0-$4,153,9412024-08-14
Q1 2024Karuna Therapeutics Inc
CUSIP 48576A100
United StatesCommon53,2790-53,279$16,863,336$0-$16,863,3362024-05-15
Q1 2024CYMABAY THERAPEUTICS INC
CUSIP 23257D103
United StatesCommon611,1810-611,181$14,436,095$0-$14,436,0952024-05-15
Q1 2024Harpoon Therapeutics, Inc.
CUSIP 41358P205
United StatesCommon319,6700-319,670$3,634,648$0-$3,634,6482024-05-15
Q1 2024Inozyme Pharma Inc.
CUSIP 45790W108
United StatesCommon323,8130-323,813$1,379,443$0-$1,379,4432024-05-15

Similar Firms

Firm NameCountry13F ValueHoldings
MAINSTAY CAPITAL MANAGEMENT LLC /ADVUnited States$1.297B143
Private Wealth Partners, LLCUnited States$1.298B169
ALTA CAPITAL MANAGEMENT LLC/United States$1.291B100
Greenbrier Partners Capital Management, LLCUnited States$1.298B11
a16z Capital Management, L.L.C.United States$1.291B16
Penn Capital Management Company, LLCUnited States$1.290B172
Charter Oak Capital Management, LLCUnited States$1.290B211
MONECO ADVISORS, LLCUnited States$1.289B515
Silver Point Capital L.P.United States$1.301B16
HIMENSION CAPITAL (SINGAPORE) PTE. LTD.Singapore$1.302B135